Dogs live alongside us and are exposed to the same environments. They exercise with us, eat our food, drink the same water. That's why researchers believe dogs may be one of man's best hopes to treat age related illnesses.>> Cancer, dementia, all these diseases that we see as humans age occur in dogs. >> And you believe looking at dogs can help us not only help dogs but but humans as well. >> Yes, of course.Absolutely. ...

It was many years back one summer. It was very very hot summer the March. I was having a long journey of 9 months. I really enjoyed this 9 months journey.Then suddenly that day I felt little cool. Why. Because there was a heavy rain one day before in the west coast of India.There was a lot of wind was coming and I was really enjoying. Then suddenly there was a push that I came out in this world. That was the day I was born and then I went to many many roller coaster in the life.One instant I know very sure ...

We found chemicals in these products that are associated with cancer, reproductive harm, and also birth defects. >> A style often deemed as protective for black women is now under scrutiny as two new studies warn of health risks in hair extensions. Consumer Reports revealing new findings that human, synthetic, and plant-based hair extensions from 30 brands have volatile organic compounds or heavy metals like lead.Human hair by far had the most lead that we've ever seen in testing these products. Orders of m ...

Deadbolts, padlocks, mortise locks, cam locks, combination locks to name a few. Why so many locks. Well, I purchased and fashioned them in response to trauma.Yes. Trauma. When I was 15 years old, my little brother died.He died by suicide. He was 12. And I was never the same.Since losing my little brother, it's as if I've had this very peculiar relationship with suicidality. It's like a strange push and pull, as if it's pulling on me constantly. But I've learned how to resist sometimes with more strength tha ...

Keď mi zavolala Oli Džupinková, že Willy, počuj, môžeš dôjsť na TEDX a porozprávať o svojom príbehu, tak som povedal, jasné, kedy, kde, ako, čo a až potom mi došlo, že vlastne čo ja tu budem rozprávať, hej. Eh, tá téma rakoviny a rakovina proste na Slovensku je fakt, že tabu a spája sa s tým smrť, spája sa s tým strach, čo je úplne prirodzené. Ale povedal som si, že ak to má byť o nejakých vzoroch viditeľných, neviditeľných, tak prídem veľmi rád, lebo eh mne aj takéto nejaké vzory a nejaké takéto veci v rám ...

Core Insights - Rigel Pharmaceuticals reported strong financial results for Q4 and full year 2025, with record net product sales and total revenues, setting a positive outlook for 2026 [1][2] Financial Performance - Total revenues for Q4 2025 were approximately $69.8 million, including net product sales of $65.4 million, a 41% increase from Q4 2024 [2][4] - For the full year 2025, total revenues reached approximately $294.3 million, with net product sales of $232.0 million, reflecting a 60% increase from 2024 [2][4] - Rigel reported a net income of $268.1 million for Q4 2025 and $367.0 million for the full year, significantly up from $14.3 million in Q4 2024 [2][4] Product Sales - Net product sales for TAVALISSE® were $45.6 million in Q4 2025, a 47% increase from Q4 2024, while GAVRETO® and REZLIDHIA® saw sales of $10.2 million and $9.6 million respectively, marking increases of 27% and 29% [2][4] - For the full year 2025, TAVALISSE® sales were $158.8 million, GAVRETO® sales were $42.1 million (up 146%), and REZLIDHIA® sales were $31.0 million (up 35%) compared to 2024 [2][4] Clinical Development - Enrollment in the Phase 1b study of R289 for lower-risk MDS is ongoing, with completion expected in the second half of 2026 [1][2] - The FDA approved a supplemental New Drug Application for GAVRETO, adding a boxed warning regarding serious infections [1][2] - Rigel presented data at the ASCO-GI symposium showing a 67% overall response rate for pralsetinib in patients with RET fusion-positive solid tumors [1][2] 2026 Outlook - Rigel anticipates total revenues of approximately $275 to $290 million for 2026, including net product sales of $255 to $265 million and positive net income [1][2]

A new study found that the likelihood of a cancer patient committing a crime is 14% higher than among people yet to develop the disease https://t.co/42lu0EQBvg ...

In Breaking Bad a mild-mannered chemistry teacher reinvents himself as a drug lord after learning he has terminal cancer. A new study suggests the plot is less outlandish than it seems https://t.co/42lu0EQBvg ...

Studies consistently show that the more fibre people eat, up to 25-30g a day, the lower the risk of cancer, diabetes and heart disease. But being laser-focused on the stuff can have risks https://t.co/8WoaM5RBOt ...

“Two years and 11 doctors later, I learned that my stubborn itch had nothing to do with menopause, perimenopause or hormones,” writes Jessica Toonkel. “I had cancer.” https://t.co/LMMvIUCSi8 https://t.co/L3EReuAq0n ...